Skip navigation
Agenda

Navigate the Evolving Managed Care Landscape, Identify Emerging Models in Utilization Management, and Elevate Strategies to Enhance Product Access

August 15-16, 2018
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, AUGUST 15, 2018

7:30

Conference Registration and Networking Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

Ira Klein, MD, MBA, FACP
Senior Director, Healthcare Quality Strategy
Johnson & Johnson Health Care Systems Inc.

8:45

POLICY OUTLOOK Navigate the Future of Coverage and Access in the Changing Health Policy Landscape

Kip Piper, MA, FACHE
President
Health Results Group, LLC

9:30

ENFORCEMENT OVERSIGHT Trends in Enforcement and Oversight —
What Companies Can Do to Ensure Compliance

MODERATOR:

John Richter
Partner, King & Spalding LLP
former U.S. Attorney
U.S. Attorney’s Office for the Western District of Oklahoma

PANELISTS:

Paul W. Kaufman
Assistant U.S. Attorney, Civil Division
U.S. Attorney’s Office for the Eastern District of Pennsylvania

Vikas Khanna
Assistant U.S. Attorney
U.S. Attorney’s Office for the District of New Jersey

10:15

Networking and Refreshment Break

10:45

Emerging Trends in PBM Restrictions on Commercial Copay Assistance

Corey Ford, MHA
Director, Reimbursement and Policy Insights
Xcenda

Jim Dickey
Director, Product Experience
Lash Group

11:30

PANEL Strategies to Overcome Payer Controls to Achieve Optimal Access

MODERATOR:

Dina Inverso
U.S. Strategy Leader, Reimbursement and Patient Engagement
CSL Behring

PANELISTS:

Bill Goodson
Director, Patient Access and Reimbursement Services
Eisai, Inc.

Rob Laverty
Vice President, Market Access
Braeburn

Melissa Masterson
Senior Vice President, Market Access,
Distribution and Commercial Operations
Adamas Pharmaceuticals, Inc.

12:15

Networking Luncheon

1:30

Trends in Prescription Drug Coverage, Formulary Design and Pharmacy Management

Gregory Gierer
Senior Vice President, Policy
America’s Health Insurance Plan (AHIP)

Alex Keeton
Director, Policy Research and Analytics
BIO

2:15

Specialty Pharmacy Report — Outlook on Current and Future Trends

Randy Maloziec
Vice President, BioPharma Relations
US Bioservices, an AmerisourceBergen Specialty Company

3:00

Networking and Refreshment Break

3:30

CHOOSE BETWEEN TWO SUMMITS (1-2)

1 Reimbursement and Access 101 Boot Camp

Kesslyn Smith
Reimbursement and Patient Access
formerly with Sandoz, Otsuka and Sanofi

Meghan Hover Szczech
Director, Patient Services
Ipsen Biopharmaceuticals, Inc.

2 New Product Launch Strategy Summit

Lesly Charanza
Vice President, Market Access, Oncology
Heron Therapeutics

Kris Thiruvillakkat
Global Market Access Strategist
Pfizer Inc

Ron Godsey
Senior Director, Market Access and Reimbursement
Heron Therapeutics

5:00

Close of Summits and Day One

Networking, Wine & Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, AUGUST 16, 2018

8:00

Networking Breakfast

8:30

Conference Chairman’s Review of Day One

Ira Klein, MD, MBA, FACP
Senior Director, Healthcare Quality Strategy
Johnson & Johnson Health Care Systems Inc.

8:45

HEALTHCARE INNOVATION SPOTLIGHT Encouraging Innovation in Value-Based Care and Healthcare Delivery

Murray Ross, PhD
Vice President, Kaiser Permanente;
Director, Kaiser Permanente Institute for Health Policy

9:30

Leveraging Value Frameworks to Enhance Stakeholder Collaboration

Michael Ruiz de Somocurcio
Vice President, Payer and Provider Collaboration
Regional Cancer Care Associates LLC

10:15

Key Considerations for the Design and Execution of Value-Based
Contracting for Drugs and Devices

John Linnehan
Vice President, Client Solutions
Avalere, an Inovalon Company

Jay Jackson
Senior Manager
Avalere, an Inovalon Company

Rujul Desai
Of Counsel
Covington & Burling

11:00

Networking and Refreshment Break

11:30

CHOOSE BETWEEN TWO TOPIC INTENSIVES (A-B)

A Considerations for Biosimilar Strategy and Access

Molly Burich, MS
Director, Public Policy – Biosimilars and Reimbursement
Boehringer Ingelheim

BResearch Strategies and Tools to Optimize Payer Engagement

Gina Ewy
Director, Market Access
Jupiter Life Sciences Consulting

12:15

Networking Luncheon

CHOOSE BETWEEN TWO TOPIC INTENSIVES (C-D)

C Ex-U.S. Pricing and Market Access Strategy

Anindita Sinha
Director, Global Market Access
Pfizer Inc

DPrior Authorizations and Benefit Verification Processes — The Good, The Bad and The Ugly

Jesse C. Dresser, Esq.
Partner
Frier Levitt, LLC

2:00

CHOOSE BETWEEN TWO TOPIC INTENSIVES (E-F)

E Coverage and Reimbursement of Novel Cell and Gene Therapies

Sarah Pitluck
Head, Global Pricing and Reimbursement
Spark Therapeutics

FBridging the Gap to PatientAccess — Temporary Supply and Quick Start Programs

Kevin Fitzgerald
Counsel, Business Legal
AbbVie

Scott Brewster
Vice President, Head of Operations and Patient Access, North America
Sobi, Inc.

2:45

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, AUGUST 15, 2018

7:30

Conference Registration and Networking Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

Ira Klein, MD, MBA, FACP
Senior Director, Healthcare Quality Strategy
Johnson & Johnson Health Care Systems Inc.

8:45

POLICY OUTLOOK Navigate the Future of Coverage and Access in the Changing Health Policy Landscape

Kip Piper, MA, FACHE
President
Health Results Group, LLC

9:30

ENFORCEMENT OVERSIGHT Trends in Enforcement and Oversight —
What Companies Can Do to Ensure Compliance

MODERATOR:

John Richter
Partner, King & Spalding LLP
former U.S. Attorney
U.S. Attorney’s Office for the Western District of Oklahoma

PANELISTS:

Paul W. Kaufman
Assistant U.S. Attorney, Civil Division
U.S. Attorney’s Office for the Eastern District of Pennsylvania

Vikas Khanna
Assistant U.S. Attorney
U.S. Attorney’s Office for the District of New Jersey

10:15

Networking and Refreshment Break

10:45

Emerging Trends in PBM Restrictions on Commercial Copay Assistance

Corey Ford, MHA
Director, Reimbursement and Policy Insights
Xcenda

Jim Dickey
Director, Product Experience
Lash Group

11:30

PANEL Strategies to Overcome Payer Controls to Achieve Optimal Access

MODERATOR:

Dina Inverso
U.S. Strategy Leader, Reimbursement and Patient Engagement
CSL Behring

PANELISTS:

Bill Goodson
Director, Patient Access and Reimbursement Services
Eisai, Inc.

Rob Laverty
Vice President, Market Access
Braeburn

Melissa Masterson
Senior Vice President, Market Access,
Distribution and Commercial Operations
Adamas Pharmaceuticals, Inc.

12:15

Networking Luncheon

1:30

Trends in Prescription Drug Coverage, Formulary Design and Pharmacy Management

Gregory Gierer
Senior Vice President, Policy
America’s Health Insurance Plan (AHIP)

Alex Keeton
Director, Policy Research and Analytics
BIO

2:15

Specialty Pharmacy Report — Outlook on Current and Future Trends

Randy Maloziec
Vice President, BioPharma Relations
US Bioservices, an AmerisourceBergen Specialty Company

3:00

Networking and Refreshment Break

3:30

CHOOSE BETWEEN TWO SUMMITS (1-2)

1 Reimbursement and Access 101 Boot Camp

Kesslyn Smith
Reimbursement and Patient Access
formerly with Sandoz, Otsuka and Sanofi

Meghan Hover Szczech
Director, Patient Services
Ipsen Biopharmaceuticals, Inc.

2 New Product Launch Strategy Summit

Lesly Charanza
Vice President, Market Access, Oncology
Heron Therapeutics

Kris Thiruvillakkat
Global Market Access Strategist
Pfizer Inc

Ron Godsey
Senior Director, Market Access and Reimbursement
Heron Therapeutics

5:00

Close of Summits and Day One

Networking, Wine & Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, AUGUST 16, 2018

8:00

Networking Breakfast

8:30

Conference Chairman’s Review of Day One

Ira Klein, MD, MBA, FACP
Senior Director, Healthcare Quality Strategy
Johnson & Johnson Health Care Systems Inc.

8:45

HEALTHCARE INNOVATION SPOTLIGHT Encouraging Innovation in Value-Based Care and Healthcare Delivery

Murray Ross, PhD
Vice President, Kaiser Permanente;
Director, Kaiser Permanente Institute for Health Policy

9:30

Leveraging Value Frameworks to Enhance Stakeholder Collaboration

Michael Ruiz de Somocurcio
Vice President, Payer and Provider Collaboration
Regional Cancer Care Associates LLC

10:15

Key Considerations for the Design and Execution of Value-Based
Contracting for Drugs and Devices

John Linnehan
Vice President, Client Solutions
Avalere, an Inovalon Company

Jay Jackson
Senior Manager
Avalere, an Inovalon Company

Rujul Desai
Of Counsel
Covington & Burling

11:00

Networking and Refreshment Break

11:30

CHOOSE BETWEEN TWO TOPIC INTENSIVES (A-B)

A Considerations for Biosimilar Strategy and Access

Molly Burich, MS
Director, Public Policy – Biosimilars and Reimbursement
Boehringer Ingelheim

BResearch Strategies and Tools to Optimize Payer Engagement

Gina Ewy
Director, Market Access
Jupiter Life Sciences Consulting

12:15

Networking Luncheon

CHOOSE BETWEEN TWO TOPIC INTENSIVES (C-D)

C Ex-U.S. Pricing and Market Access Strategy

Anindita Sinha
Director, Global Market Access
Pfizer Inc

DPrior Authorizations and Benefit Verification Processes — The Good, The Bad and The Ugly

Jesse C. Dresser, Esq.
Partner
Frier Levitt, LLC

2:00

CHOOSE BETWEEN TWO TOPIC INTENSIVES (E-F)

E Coverage and Reimbursement of Novel Cell and Gene Therapies

Sarah Pitluck
Head, Global Pricing and Reimbursement
Spark Therapeutics

FBridging the Gap to PatientAccess — Temporary Supply and Quick Start Programs

Kevin Fitzgerald
Counsel, Business Legal
AbbVie

Scott Brewster
Vice President, Head of Operations and Patient Access, North America
Sobi, Inc.

2:45

Close of Conference